The Israeli institute will share its expertise on translating research into commercially viable applications with the goal of advancing personalized medicine.
Researchers are developing a nanopore sensing device that relies on restriction enzymes to target specific clinically relevant variants in pathogens.
Technion's Reut Shalgi is building up her lab to study how chaperones affect protein synthesis and protein folding.
The majority of the funding will be used to establish a cancer metabolomics research center on Technion's campus.
Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.
According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.
In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.
CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.